
Tue 1 July 2025
Warszawa (PL)
24/12°C
Mon
|
Tue
|
Wed
|
Thu
|
Fri
|
23 |
27 |
29 |
35 |
22 |
Tue 1 July 2025
Praha (CZ)
31/17°C
Mon
|
Tue
|
Wed
|
Thu
|
Fri
|
31 |
34 |
35 |
36 |
28 |
Tue 1 July 2025
Bratislava (SK)
30/15°C
Mon
|
Tue
|
Wed
|
Thu
|
Fri
|
32 |
31 |
33 |
35 |
31 |
Tue 1 July 2025
Budapest (HU)
29/21°C
Mon
|
Tue
|
Wed
|
Thu
|
Fri
|
34 |
33 |
32 |
36 |
34 |



February 8th, 2021
The Health Ministry will recommend the use of the drugs for COVID-19 based on monoclonal antibodies, namely kasirivimab and imdevimab from the Regeneron firm and bamlanivimab from the Eli Lilly firm, it said in a press release today. These drugs are suitable for people with a high risk of severe symptoms of the infection disease, for example patients after transplants. The target groups are yet to be defined.
CTK
Pageviews this month:
890